CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Power3 Medical Products, Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Power3 Medical Products, Inc.
Suite B2-3, 3400 RESEARCH FOREST DR
Phone: (281) 466-1600p:281 466-1600 THE WOODLANDS, TX  77381  United States Fax: (281) 363-7935f:281 363-7935
On 12/18/2014, the U.S. Securities and Exchange Commission revoked the registration of each class of registered securities of Power3 Medical Products, Inc. for failure to make required periodic filings with the Commission.
This company is no longer actively traded on any major stock exchange.
Business Summary
Power3 Medical Products, Inc. (Power3) is a biotechnology company focused on the development and marketing of diagnostic products through the analysis of proteins. It is focused on the development of diagnostic tests in the fields of cancer, and neurodegenerative and neuromuscular diseases, such as amytrophic lateral sclerosis (ALS) (also known as Lou Gehrig’s disease), Alzheimer’s disease and Parkinson’s disease. It also addresses clinical questions related to early disease detection, treatment response, monitoring of disease progression, prognosis and others through collaborations with academic and research institutions. Power3 applies its methodologies to discover and identify protein biomarkers associated with diseases. It has developed a portfolio of products, including BC-SeraPro, a proteomic blood serum test for the early detection of breast cancer, and NuroPro, a serum test for the detection of neurodegenerative diseases, including Alzheimer’s, Parkinson’s and ALS diseases.
(Source: 10-K)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/201112/31/2010YesYes--Yes

Industries
SIC Code Description
8731 Commercial physical and biological research
2835 In vitro and in vivo diagnostic substances

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Interim Chairman of the Board, President, Chief Scientific Officer Ira L.Goldknopf 64 9/4/2008 5/18/2004
Interim Chief Executive Officer, Interim Chief Financial Officer, Director Helen R.Park 75 12/7/2009 9/7/2008

Business Names
Business Name
Power 3 Medical Products, Inc.
Power3 Medical Products, Inc.
TenthGate, Inc.

General Information
Number of Employees: 1 (As of 9/30/2011)
Outstanding Shares: 571,632,952 (As of 11/10/2011)
Shareholders: 1,182
Stock Exchange: OTC
Federal Tax Id: 650565144
Fax Number: (281) 363-7935


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023